Results 91 to 100 of about 672,472 (195)

Development of a Low-Barrier, Reimbursable Take-Home Naloxone Program at a Regional Health System. [PDF]

West J Emerg Med
London KS, Patel S, Lockstein D, Rashid J, Goodstein D, Pacitti R, Warrick-Stone T, Randolph F, Cherney A, Alexander K, Reed M.   +10 more
europepmc   +1 more source

Emergency Department-initiated standard versus high-dose buprenorphine induction (ENVISION): a randomised clinical trial protocol. [PDF]

BMJ Open
Hawk K, Herring A, Chawarski M, Anderson ES, Baumann M, Dorey A, Holtyn AF, Jones C, Martel S, Owens P, Kmiecik K, Strout TD, Taillac P, Lofwall M, Walsh SL, D'Onofrio G.   +15 more
europepmc   +1 more source

Adjunctive Psychosocial Interventions and Opioid Abstinence Among Patients Receiving Buprenorphine: A Randomized Clinical Trial.

JAMA Netw Open
Lent MR, Hurstak EE, Lynch KG, Loscalzo E, Mazur K, Lugo HL, Dugosh KL.   +6 more
europepmc   +1 more source

Therapeutic Potential of Naltrexone in the Niche of Psychopharmacology. [PDF]

Psychopharmacol Bull
Naguy A, Alamiri B.
europepmc   +1 more source

Developments in the Study of Inert Gas Biological Effects and the Underlying Molecular Mechanisms. [PDF]

Int J Mol Sci
Tong MN, Li X, Cheng J, Jiang ZL.
europepmc   +1 more source

Patterns of polysubstance use among people who use drugs on an American Indian reservation of a southern plains Tribal Nation. [PDF]

Harm Reduct J
Schneider KE, Allen ST, O'Rourke A, Reid M, Conrad M, Garrett B, Hautala D, Lewis K, Lewis S, Wilson L, Walls M.   +10 more
europepmc   +1 more source

Prevalence of AAS-Positive Samples at Drug Abuse Laboratory Sweden Between 2014 and 2023 and Sub-Study of Dual Use of AAS and Narcotics. [PDF]

Drug Test Anal
Bohlin KP, Villén T, Hopcraft O, Pohanka A, Ekström L.   +4 more
europepmc   +1 more source

The NOD (Naltrexone for Overdose Prevention) study protocol: a pilot randomized controlled trial of intramuscular naltrexone for opioid overdose prevention among people who use stimulants living with or at risk for HIV. [PDF]

Addict Sci Clin Pract
Appa A, Marti XL, Baral S, Shoptaw S, Bazazi AR, Spinelli MA, Glidden D, Gandhi M, Coffin P.   +8 more
europepmc   +1 more source

Factors Influencing Treatment Outcomes in a Randomized Clinical Trial for Gambling Disorder: A Secondary Analysis.

Eur Addict Res
Mäkelä N, Isotalo J, Alho H, Castrén S.   +3 more
europepmc   +1 more source